Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on bronchiectasis.

M A Moreschi1, S B Fiel

  • 1Department of Pulmonary and Critical Care Medicine, The Medical College of Pennsylvania, Philadelphia, Pennsylvania 19129, USA.

Current Opinion in Pulmonary Medicine
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

History and evolution of aerosolized therapeutics: overview and introduction.

Chest·2001
Same author

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.

American journal of respiratory and critical care medicine·2000
Same author

Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.

Pediatric pulmonology·1998
Same author

Cystic fibrosis.

Current opinion in pulmonary medicine·1997
Same author

High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation.

AJR. American journal of roentgenology·1997
Same author

Pregnancy in patients with cystic fibrosis.

Pediatric pulmonology. Supplement·1997
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Bronchiectasis involves airway inflammation and dilation, often linked to genetic conditions like cystic fibrosis. Early diagnosis and management, including new therapies, can improve outcomes for patients with this lung disease.

Area of Science:

  • Pulmonology
  • Medical Imaging
  • Genetics

Background:

  • Bronchiectasis is a chronic lung condition characterized by irreversible bronchial dilation and persistent inflammation.
  • It is associated with various predisposing factors, including hereditary disorders like cystic fibrosis, ciliary dyskinesia, and immunodeficiencies.
  • Bronchiectasis contributes significantly to morbidity and mortality, necessitating a deeper understanding of its pathogenesis.

Purpose of the Study:

  • To review the heterogeneous predisposing conditions associated with bronchiectasis.
  • To highlight the role of inflammatory mediators in the pathogenesis of bronchiectasis.
  • To discuss diagnostic modalities and potential therapeutic strategies for bronchiectasis.

Main Methods:

  • Literature review focusing on recent investigations into bronchiectasis.

Related Experiment Videos

  • Analysis of the diagnostic utility of computed tomography (CT) and high-resolution CT (HRCT).
  • Examination of treatment outcomes in cystic fibrosis and potential applications for other bronchiectasis populations.

    • Main Results:

    • High-resolution computed tomography (HRCT) is the preferred diagnostic tool for bronchiectasis.
    • CT and HRCT have identified bronchiectasis in conditions such as HIV and alpha-1-antitrypsin deficiency.
    • Early identification and aggressive management, similar to cystic fibrosis protocols, may improve survival and reduce morbidity in other bronchiectasis patients.

    Conclusions:

    • Bronchiectasis management can benefit from early identification of underlying disorders and proactive symptom control.
    • Newer treatments, like recombinant human DNase, show promise in improving pulmonary function and quality of life.
    • These advancements may extend to managing other chronic inflammatory lung diseases beyond cystic fibrosis.